<p>Doximity（纽约证券交易所代码：DOCS - 获取免费报告）在周四发布的报告中，Needham &amp; Company LLC 将其目标价格从 55.00 美元下调至 27.00 美元，Benzinga 报道。该券商目前对该股票给予 “买入” 评级。Needham &amp; Company LLC 的目标价格暗示该公司当前价格有 14.82% 的潜在上涨空间。</p>
<ul>
<li>Doximity 是医疗社区的 Facebook 和 LinkedIn</li>
</ul>
<p>其他几家股票研究分析师也对 DOCS 发布了报告。BTIG Research 在周四将 Doximity 的评级从 “买入” 下调至 “中性”。摩根大通将 Doximity 的目标价格从 40.00 美元下调至 33.00 美元，并在 2 月 20 日的报告中对该公司给予 “中性” 评级。加拿大皇家银行在 3 月 9 日的报告中重申了 “跑赢大盘” 评级，并对 Doximity 的股票设定了 44.00 美元的目标价格。Canaccord Genuity Group 在 2 月 9 日的报告中对 Doximity 设定了 34.00 美元的目标价格，并给予该股票 “买入” 评级。最后，BMO 资本市场在 2 月 6 日的报告中对 Doximity 设定了 25.00 美元的目标价格。两位投资分析师对该股票给予了强烈买入评级，九位给予了买入评级，十二位给予了持有评级。根据 MarketBeat.com 的数据，该公司目前的共识评级为 “适度买入”，平均目标价格为 33.60 美元。</p>
<p><strong>阅读我们关于 DOCS 的最新报告</strong></p>
<h2>Doximity 股价下跌 11.1%</h2>
<ul>
<li>Doximity 是一个被忽视的医疗生态系统 AI 投资</li>
</ul>
<p>Doximity 的股票在周四开盘价为 23.52 美元。该公司的市值为 43.4 亿美元，市盈率为 19.60，市盈增长比率为 1.88，贝塔值为 1.36。Doximity 的 52 周低点为 20.55 美元，52 周高点为 76.51 美元。该公司的 50 日移动平均价格为 24.27 美元。</p>
<p>Doximity 宣布其董事会于 2 月 5 日启动了一项股票回购计划，允许公司回购 5 亿美元的流通股。该回购授权允许公司通过公开市场购买最多 8% 的股票。股票回购计划通常表明公司的管理层认为其股票被低估。</p>
<h2>内部买卖</h2>
<ul>
<li>Doximity 股票是一个有趣的医疗投资</li>
</ul>
<p>在其他新闻中，董事 Kira Scherer Wampler 在 5 月 7 日的交易中出售了 9,000 股公司的股票。该股票以平均价格 26.06 美元出售，总交易额为 234,540.00 美元。出售后，该董事直接持有公司 19,839 股，价值约 517,004.34 美元。此次交易使其持股减少了 31.21%。该交易已在向 SEC 提交的文件中披露，SEC 网站可查阅。该交易是在预先安排的 10b5-1 交易计划下执行的。此外，内部人士 Siddharth Sitaram 在 5 月 11 日的交易中出售了 2,309 股公司的股票。该股票以平均价格 25.77 美元出售，总价值为 59,502.93 美元。出售后，该内部人士持有公司 89,396 股，价值约 2,303,734.92 美元。这代表其持股减少了 2.52%。此次出售的披露可在 SEC 文件中找到。该交易是在预先安排的 10b5-1 交易计划下执行的。此次出售是为了覆盖与股权奖励归属相关的税款扣缴义务。在过去 90 天内，内部人士已出售 18,055 股公司股票，价值 456,061 美元。31.30% 的股票目前由公司内部人士持有。</p>
<h2>机构投资者对 Doximity 的看法</h2>
<p>一些对冲基金最近对该公司的持仓进行了调整。先锋集团在第四季度将其在 Doximity 的持股增加了 4.1%。先锋集团目前拥有 13,285,485 股公司股票，价值 588,281,000 美元，此前在上个季度增持了 518,916 股。Aubrey Capital Management Ltd 在第三季度购买了 Doximity 的新头寸，价值约 4,572,000 美元。瑞银集团在第四季度将其在 Doximity 的持股增加了 26.5%。瑞银集团目前拥有 680,260 股公司股票，价值 30,122,000 美元，此前在该期间增持了 142,408 股。Blair William &amp; Co. IL 在第三季度将其在 Doximity 的持股增加了 1,990.7%。Blair William &amp; Co. IL 目前拥有 362,740 股公司股票，价值 26,534,000 美元，此前在该期间增持了 345,390 股。最后，William Blair Investment Management LLC 在第三季度将其在 Doximity 的持股增加了 11.7%。William Blair Investment Management LLC 目前拥有 5,829,169 股公司股票，价值 426,404,000 美元，此前在该期间增持了 609,775 股。机构投资者和对冲基金持有该公司 87.19% 的股票。</p>
<h2>影响 Doximity 的主要新闻</h2>
<p>以下是本周影响 Doximity 的主要新闻故事：</p>
<ul>
<li>积极情绪：Doximity 报告调整后每股收益为 0.26 美元，超出分析师较低预期的 0.17 美元，收入同比增长 5.1%，达到 1.4537 亿美元，显示出业务仍在增长。Doximity 财报</li>
<li>中性情绪：公司的高利润率保持不变，股本回报率为 23.84%，净利润率为 37.54%，表明持续的运营效率。2026 财年第四季度财报快照</li>
<li>消极情绪：尽管每股收益超出一个预期，但 Doximity 未能达到更广泛的 Zacks 共识 0.28 美元，这可能让寻求更强劲超预期的交易者感到失望。Doximity 落后于第四季度收益预期</li>
<li>消极情绪：对投资者来说，更重要的是，Doximity 2027 财年第一季度的收入指引为 1.51 亿至 1.52 亿美元，低于 1.532 亿美元的共识，2027 财年全年的收入指引为 6.64 亿至 6.76 亿美元，也低于 6.96 亿美元的预期，发出较软的前景信号。Doximity 2026 财年第四季度电话会议记录</li>
<li>消极情绪：该股票还因本周早些时候的内部交易而面临额外的谨慎，尽管这被披露为预先安排的 10b5-1 计划和与股权归属相关的税收扣缴。内部交易披露</li>
</ul>
<h2>关于 Doximity</h2>
<p>(获取免费报告)</p>
<p>Doximity（股票代码：DOCS）运营一个数字专业网络和通讯平台，主要为临床医生设计。公司总部位于旧金山，连接医生、护士执业者、医师助理及其他医疗专业人员，提供简化临床沟通、远程医疗交付和获取专业特定医疗信息的工具。其平台被定位为一个专业中心，临床医生在此管理工作流程，保持医学新闻的最新动态，并与同行安全协作。</p>
<p>该公司的产品包括安全消息传递和视频远程医疗功能，使临床医生能够在保护患者信息的同时与患者和同事进行咨询。</p>
<h2>了解更多</h2>
<ul>
<li>我们更看好的五只股票，胜过 Doximity</li>
<li>保持航班正常的飞机维修公司准备腾飞</li>
<li>Oklo 股票可能准备再次大幅上涨</li>
<li>D-Wave 财报看起来疲弱，但投资者可能错过了这一点</li>
<li>随着 AI 反馈循环加剧，Nebius 上行空间扩大</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPURPQ1M?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="650" height="330" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPURPQ1M"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Doximity 吗？</h2>
<p>在考虑 Doximity 之前，你会想听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Doximity 并不在名单上。</p>
<p>虽然 Doximity 目前在分析师中获得中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

DOCS

LGHT

HEAL

<p>Needham & Company LLC 将 Doximity (NYSE:DOCS) 的目标股价从 55.00 美元下调至 27.00 美元，同时维持 “买入” 评级。这表明从当前价格来看，潜在上涨幅度为 14.82%。其他分析师也调整了他们的评级，BTIG Research 将评级下调至 “中性”，摩根大通将目标价下调至 33.00 美元。Doximity 的股票开盘价为 23.52 美元，市值为 43.4 亿美元。该公司已启动 5 亿美元的股票回购计划，表明管理层对股票被低估的信心</p>

<p>Doximity (NYSE:DOCS - Get Free Report) had its price target dropped by analysts at Needham &amp; Company LLC from $55.00 to $27.00 in a report issued on Thursday,Benzinga reports. The brokerage presently has a &#34;buy&#34; rating on the stock. Needham &amp; Company LLC's price objective suggests a potential upside of 14.82% from the company's current price.</p>
<div class="lb-trans"><p>Doximity（纽约证券交易所代码：DOCS - 获取免费报告）在周四发布的报告中，Needham &amp; Company LLC 将其目标价格从 55.00 美元下调至 27.00 美元，Benzinga 报道。该券商目前对该股票给予 “买入” 评级。Needham &amp; Company LLC 的目标价格暗示该公司当前价格有 14.82% 的潜在上涨空间。</p>
</div><ul>
<li>Doximity is the Facebook and LinkedIn of the Medical Community</li>
</ul>
<div class="lb-trans"><ul>
<li>Doximity 是医疗社区的 Facebook 和 LinkedIn</li>
</ul>
</div><p>Several other equities research analysts have also issued reports on DOCS. BTIG Research lowered Doximity from a &#34;buy&#34; rating to a &#34;neutral&#34; rating in a report on Thursday. JPMorgan Chase &amp; Co. reduced their target price on Doximity from $40.00 to $33.00 and set a &#34;neutral&#34; rating for the company in a report on Friday, February 20th. Royal Bank Of Canada restated an &#34;outperform&#34; rating and issued a $44.00 target price on shares of Doximity in a report on Monday, March 9th. Canaccord Genuity Group set a $34.00 price target on Doximity and gave the stock a &#34;buy&#34; rating in a report on Monday, February 9th. Finally, BMO Capital Markets set a $25.00 price target on Doximity in a report on Friday, February 6th. Two investment analysts have rated the stock with a Strong Buy rating, nine have assigned a Buy rating and twelve have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of &#34;Moderate Buy&#34; and an average target price of $33.60.</p>
<div class="lb-trans"><p>其他几家股票研究分析师也对 DOCS 发布了报告。BTIG Research 在周四将 Doximity 的评级从 “买入” 下调至 “中性”。摩根大通将 Doximity 的目标价格从 40.00 美元下调至 33.00 美元，并在 2 月 20 日的报告中对该公司给予 “中性” 评级。加拿大皇家银行在 3 月 9 日的报告中重申了 “跑赢大盘” 评级，并对 Doximity 的股票设定了 44.00 美元的目标价格。Canaccord Genuity Group 在 2 月 9 日的报告中对 Doximity 设定了 34.00 美元的目标价格，并给予该股票 “买入” 评级。最后，BMO 资本市场在 2 月 6 日的报告中对 Doximity 设定了 25.00 美元的目标价格。两位投资分析师对该股票给予了强烈买入评级，九位给予了买入评级，十二位给予了持有评级。根据 MarketBeat.com 的数据，该公司目前的共识评级为 “适度买入”，平均目标价格为 33.60 美元。</p>
</div><p><strong>Read Our Latest Report on DOCS</strong></p>
<div class="lb-trans"><p><strong>阅读我们关于 DOCS 的最新报告</strong></p>
</div><h2>Doximity Trading Down 11.1%</h2>
<div class="lb-trans"><h2>Doximity 股价下跌 11.1%</h2>
</div><ul>
<li>Doximity is an Overlooked Medical Ecosystem AI Play</li>
</ul>
<div class="lb-trans"><ul>
<li>Doximity 是一个被忽视的医疗生态系统 AI 投资</li>
</ul>
</div><p>Shares of Doximity stock opened at $23.52 on Thursday. The firm has a market cap of $4.34 billion, a price-to-earnings ratio of 19.60, a price-to-earnings-growth ratio of 1.88 and a beta of 1.36. Doximity has a 52-week low of $20.55 and a 52-week high of $76.51. The firm's 50-day moving average price is $24.27.</p>
<div class="lb-trans"><p>Doximity 的股票在周四开盘价为 23.52 美元。该公司的市值为 43.4 亿美元，市盈率为 19.60，市盈增长比率为 1.88，贝塔值为 1.36。Doximity 的 52 周低点为 20.55 美元，52 周高点为 76.51 美元。该公司的 50 日移动平均价格为 24.27 美元。</p>
</div><p>Doximity announced that its board has initiated a share repurchase plan on Thursday, February 5th that permits the company to buyback $500.00 million in outstanding shares. This buyback authorization permits the company to purchase up to 8% of its stock through open market purchases. Stock buyback plans are typically an indication that the company's management believes its stock is undervalued.</p>
<div class="lb-trans"><p>Doximity 宣布其董事会于 2 月 5 日启动了一项股票回购计划，允许公司回购 5 亿美元的流通股。该回购授权允许公司通过公开市场购买最多 8% 的股票。股票回购计划通常表明公司的管理层认为其股票被低估。</p>
</div><h2>Insider Buying and Selling</h2>
<div class="lb-trans"><h2>内部买卖</h2>
</div><ul>
<li>Doximity Stock is an Interesting Healthcare Play</li>
</ul>
<div class="lb-trans"><ul>
<li>Doximity 股票是一个有趣的医疗投资</li>
</ul>
</div><p>In other news, Director Kira Scherer Wampler sold 9,000 shares of the business's stock in a transaction that occurred on Thursday, May 7th. The stock was sold at an average price of $26.06, for a total transaction of $234,540.00. Following the sale, the director directly owned 19,839 shares in the company, valued at approximately $517,004.34. The trade was a 31.21% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Siddharth Sitaram sold 2,309 shares of the business's stock in a transaction that occurred on Monday, May 11th. The shares were sold at an average price of $25.77, for a total value of $59,502.93. Following the sale, the insider owned 89,396 shares in the company, valued at approximately $2,303,734.92. This represents a 2.52% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last 90 days, insiders have sold 18,055 shares of company stock worth $456,061. 31.30% of the stock is currently owned by company insiders.</p>
<div class="lb-trans"><p>在其他新闻中，董事 Kira Scherer Wampler 在 5 月 7 日的交易中出售了 9,000 股公司的股票。该股票以平均价格 26.06 美元出售，总交易额为 234,540.00 美元。出售后，该董事直接持有公司 19,839 股，价值约 517,004.34 美元。此次交易使其持股减少了 31.21%。该交易已在向 SEC 提交的文件中披露，SEC 网站可查阅。该交易是在预先安排的 10b5-1 交易计划下执行的。此外，内部人士 Siddharth Sitaram 在 5 月 11 日的交易中出售了 2,309 股公司的股票。该股票以平均价格 25.77 美元出售，总价值为 59,502.93 美元。出售后，该内部人士持有公司 89,396 股，价值约 2,303,734.92 美元。这代表其持股减少了 2.52%。此次出售的披露可在 SEC 文件中找到。该交易是在预先安排的 10b5-1 交易计划下执行的。此次出售是为了覆盖与股权奖励归属相关的税款扣缴义务。在过去 90 天内，内部人士已出售 18,055 股公司股票，价值 456,061 美元。31.30% 的股票目前由公司内部人士持有。</p>
</div><h2>Institutional Investors Weigh In On Doximity</h2>
<div class="lb-trans"><h2>机构投资者对 Doximity 的看法</h2>
</div><p>A number of hedge funds have recently made changes to their positions in the company. Vanguard Group Inc. boosted its holdings in Doximity by 4.1% in the fourth quarter. Vanguard Group Inc. now owns 13,285,485 shares of the company's stock valued at $588,281,000 after acquiring an additional 518,916 shares during the last quarter. Aubrey Capital Management Ltd bought a new position in Doximity in the third quarter valued at about $4,572,000. UBS Group AG lifted its stake in Doximity by 26.5% in the fourth quarter. UBS Group AG now owns 680,260 shares of the company's stock valued at $30,122,000 after buying an additional 142,408 shares during the period. Blair William &amp; Co. IL lifted its stake in Doximity by 1,990.7% in the third quarter. Blair William &amp; Co. IL now owns 362,740 shares of the company's stock valued at $26,534,000 after buying an additional 345,390 shares during the period. Finally, William Blair Investment Management LLC lifted its stake in Doximity by 11.7% in the third quarter. William Blair Investment Management LLC now owns 5,829,169 shares of the company's stock valued at $426,404,000 after buying an additional 609,775 shares during the period. Institutional investors and hedge funds own 87.19% of the company's stock.</p>
<div class="lb-trans"><p>一些对冲基金最近对该公司的持仓进行了调整。先锋集团在第四季度将其在 Doximity 的持股增加了 4.1%。先锋集团目前拥有 13,285,485 股公司股票，价值 588,281,000 美元，此前在上个季度增持了 518,916 股。Aubrey Capital Management Ltd 在第三季度购买了 Doximity 的新头寸，价值约 4,572,000 美元。瑞银集团在第四季度将其在 Doximity 的持股增加了 26.5%。瑞银集团目前拥有 680,260 股公司股票，价值 30,122,000 美元，此前在该期间增持了 142,408 股。Blair William &amp; Co. IL 在第三季度将其在 Doximity 的持股增加了 1,990.7%。Blair William &amp; Co. IL 目前拥有 362,740 股公司股票，价值 26,534,000 美元，此前在该期间增持了 345,390 股。最后，William Blair Investment Management LLC 在第三季度将其在 Doximity 的持股增加了 11.7%。William Blair Investment Management LLC 目前拥有 5,829,169 股公司股票，价值 426,404,000 美元，此前在该期间增持了 609,775 股。机构投资者和对冲基金持有该公司 87.19% 的股票。</p>
</div><h2>Key Headlines Impacting Doximity</h2>
<div class="lb-trans"><h2>影响 Doximity 的主要新闻</h2>
</div><p>Here are the key news stories impacting Doximity this week:</p>
<div class="lb-trans"><p>以下是本周影响 Doximity 的主要新闻故事：</p>
</div><ul>
<li>Positive Sentiment: Doximity reported adjusted earnings of $0.26 per share, beating the lower analyst estimate of $0.17, and revenue rose 5.1% year over year to $145.37 million, showing the business is still growing. Doximity Earnings Report</li>
<li>Neutral Sentiment: The company’s high margin profile remained intact, with a 23.84% return on equity and 37.54% net margin, suggesting continued operational efficiency. Fiscal Q4 Earnings Snapshot</li>
<li>Negative Sentiment: Despite the earnings beat versus one estimate, Doximity missed the broader Zacks consensus of $0.28 per share, which may have disappointed traders looking for a stronger beat. Doximity Lags Q4 Earnings Estimates</li>
<li>Negative Sentiment: More importantly for investors, Doximity’s first-quarter FY2027 revenue guidance of $151 million to $152 million came in below the $153.2 million consensus, and full-year FY2027 revenue guidance of $664 million to $676 million also missed the $696 million estimate, signaling a softer outlook. Doximity Q4 2026 Earnings Call Transcript</li>
<li>Negative Sentiment: The stock also faced added caution from an insider sale earlier in the week, though it was disclosed as part of a pre-arranged 10b5-1 plan and tax withholding related to equity vesting. Insider Trade Disclosure</li>
</ul>
<div class="lb-trans"><ul>
<li>积极情绪：Doximity 报告调整后每股收益为 0.26 美元，超出分析师较低预期的 0.17 美元，收入同比增长 5.1%，达到 1.4537 亿美元，显示出业务仍在增长。Doximity 财报</li>
<li>中性情绪：公司的高利润率保持不变，股本回报率为 23.84%，净利润率为 37.54%，表明持续的运营效率。2026 财年第四季度财报快照</li>
<li>消极情绪：尽管每股收益超出一个预期，但 Doximity 未能达到更广泛的 Zacks 共识 0.28 美元，这可能让寻求更强劲超预期的交易者感到失望。Doximity 落后于第四季度收益预期</li>
<li>消极情绪：对投资者来说，更重要的是，Doximity 2027 财年第一季度的收入指引为 1.51 亿至 1.52 亿美元，低于 1.532 亿美元的共识，2027 财年全年的收入指引为 6.64 亿至 6.76 亿美元，也低于 6.96 亿美元的预期，发出较软的前景信号。Doximity 2026 财年第四季度电话会议记录</li>
<li>消极情绪：该股票还因本周早些时候的内部交易而面临额外的谨慎，尽管这被披露为预先安排的 10b5-1 计划和与股权归属相关的税收扣缴。内部交易披露</li>
</ul>
</div><h2>About Doximity</h2>
<div class="lb-trans"><h2>关于 Doximity</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(获取免费报告)</p>
</div><p>Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers.</p>
<div class="lb-trans"><p>Doximity（股票代码：DOCS）运营一个数字专业网络和通讯平台，主要为临床医生设计。公司总部位于旧金山，连接医生、护士执业者、医师助理及其他医疗专业人员，提供简化临床沟通、远程医疗交付和获取专业特定医疗信息的工具。其平台被定位为一个专业中心，临床医生在此管理工作流程，保持医学新闻的最新动态，并与同行安全协作。</p>
</div><p>The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information.</p>
<div class="lb-trans"><p>该公司的产品包括安全消息传递和视频远程医疗功能，使临床医生能够在保护患者信息的同时与患者和同事进行咨询。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>了解更多</h2>
</div><ul>
<li>Five stocks we like better than Doximity</li>
<li>Airplane Maintenance Companies That Keep Flights Moving Are Ready to Soar</li>
<li>Oklo Stock Could Be Ready for Another Massive Run</li>
<li>D-Wave Earnings Looked Weak, But Investors May Be Missing This</li>
<li>Nebius Upside Expands as AI Feedback Loop Intensifies</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票，胜过 Doximity</li>
<li>保持航班正常的飞机维修公司准备腾飞</li>
<li>Oklo 股票可能准备再次大幅上涨</li>
<li>D-Wave 财报看起来疲弱，但投资者可能错过了这一点</li>
<li>随着 AI 反馈循环加剧，Nebius 上行空间扩大</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPURPQ1M" alt="" original-src="https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NYSE&amp;Symbol=DOCS"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Doximity Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Doximity 吗？</h2>
</div><p>Before you consider Doximity, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Doximity 之前，你会想听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Doximity wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Doximity 并不在名单上。</p>
</div><p>While Doximity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Doximity 目前在分析师中获得中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Doximity (NYSE:DOCS) Given New $27.00 Price Target at Needham & Company LLC

Market Beat

Doximity

Langar Global HealthTech ETF

Global X HealthTech ETF

摩根大通

加拿大皇家银行

蒙特利尔银行

瑞银集团

JPMORGAN CHASE & CO. 4.20% DEP SHS REPSTG 1/400TH PFD SER MM

JPMORGAN CHASE & CO. 6%NON CUM DEP SHS REP 1/400TH PFD SER EE

JPMORGAN CHASE & CO. DEP REP 1/400TH (5.75% NON CUM PFD DD)

JPMORGAN CHASE & CO. 4.625% DEP SH RE 1/400TH INT NO CU PF LL

JPMorgan Chase & Co.

JPMORGAN CHASE & CO. 4.55% DEP SHS REPSTG 1/400TH PFD SER JJ

JPMORGAN CHASE & CO. 4.75 DEP SHS REP 1/400 NCUM PFD SR GG

Needham & Company LLC 给予 Doximity（NYSE:DOCS）新的 27.00 美元目标价